Lv11
8 积分 2024-12-12 加入
Five‐Year Follow‐Up: Tandem CD19 / CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non‐Hodgkin Lymphoma
6小时前
待确认
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
6个月前
已完结
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy
7个月前
已完结